26 Comments

I wonder if the Ivermectin amd Fenben treatment , that Dr. Makis is using succesfully, wouldn't help people.turn the corner with the long covid or damaged immune system.

Expand full comment

The possibilities of this leave me very hopeful for our future and future generations!

Expand full comment

I see you have asked for monetary support and clinicians but I’m neither. I am a victim of long covid . Twice! Are you treating patients at this time? That is is your system up and functioning or only in the planning stages?

Expand full comment

Neo7Bioscience is fully operational and entirely privately owned, not driven by venture capital interests. Patient care is exclusively provided through our network of participating program physicians. You may contact www.neo7bioscience.com/contactus

Expand full comment

Neo7 participating physicians are already delivering N-of-1 personalized therapeutic designs to patients.

Expand full comment

Have any other medical researchers performed any N-of-1 molecular therapeutics trials/research? If so, have they any publications or preprints?

Expand full comment

It's early in the development but these studies will be coming!

Expand full comment

In addition to the direct medical benefits of 'N-of-1' methods of validating treatments, analyzing individual variation is a fundamental principle of scientific discovery that the RCT mass-market model suppresses: https://substack.com/@peterdanielmiller/note/c-91958091

Expand full comment

I agree —you've captured it perfectly!

Expand full comment

It has long been clear that we need to look at illness/health (additionally) in a different way. Covid has made this clear once again in extremis. As a physician with additional training in homeopathic medicine, I welcome any individual approach. There is an urgent need for a different view of health care. How homeopathic medicine has approached each patient as a unique individual for more than 200 years, I write in my book Bodyguard (www.bodyguardls.be)

Léon Scheepers, M.D.

Antwerp

Belgium

Expand full comment

Many hospital injured too. This didn’t start with Covid.

Expand full comment

Could you elaborate?

Expand full comment

The OBVIOUS question is.....HOW MUCH WILL IT COST? Because you can bet that insurance won't pay for it and the little guy won't be able to afford it.

Expand full comment

This is so great.

Expand full comment

I keep hearing about peptides for skin and internal health from holistic doctors, but it begs a question. Why are people needing peptides, is our digestion weaken by toxicity/aging so much that these peptides compensate?

Expand full comment

Given the safety failures of even well-studied and carefully designed pharmaceuticals, why should patients trust the safety of an N-of-1 custom pharmaceutical produced just for them?

Expand full comment

Carefully designed pharmaceuticals?

Expand full comment

Sounds amazing, I hope injured people can afford this. It is the medical model that makes the most therapeutic sense for the vaccine injured.

Expand full comment

My 33 yr old son is in Australia and was forced to take 3 Pfizer shots, he had a accident that fractured his ankle and now was diagnosed with CRPS (complex regional pain syndrome) he’d was misdiagnosed and missed the window of a “ cure” because of the late diagnosis! Thus far his life has drastically deteriorated! They keep giving him opiod cocktails that don’t work and cause secondary psychological issues. One doctor admitted it was related to the vaccine but said “ good luck getting anyone to sign off on it”! He’s dying, and they refuse to help him! Would this trial work for him?

Expand full comment

The New Frontier starts in 10 9 8 7 6 5 4 3 2 1!

The well lived life is at your fingertips and mind.

I've got a good feeling about this!

Expand full comment

It's sound like using AI to design peptides. I'm sceptical about it because mRNA transfections were also designed by AI. Biopharma needs human guinea pigs for AI development. You can't treat disease if you don't know what was injected with easily manipulated transfections.

Expand full comment

Neo7Bioscience leverages cutting-edge Hybrid Technology, seamlessly integrating human intelligence (HI) with AI for unparalleled molecular surveillance and personalized peptide engineering. Unlike conventional approaches reliant on training models or pooled datasets, Neo7’s platform is powered by real-time patient data expressions. No elements of mRNA technology are used at any level within its pipelines. Aberrant shifts in transcription and disrupted protein-protein interactions (PPI) are clearly identified, allowing Neo7 to precisely target and mitigate these anomalies through advanced personalized peptide solutions.

Expand full comment

As one of the affected, I would go to any doctor in the country who provides this kind of approach. But where does one find such physicians?

Expand full comment

Copied from a response above

Patient care is exclusively provided through our network of participating program physicians. You may contact www.neo7bioscience.com/contactus

Expand full comment

I am grateful for your fast and helpful reply.

Expand full comment